who should avoid glp-1 medications Bariatric Surgery Vs. GLP-1: Which Weight Loss Option Fits You? There's a lot of noise

Its vital for patients to know compounded drugs are not FDA-approved medicines, Jones said

Best et al

if you don't, it's not a weakness or dependency

Microdosing does not replace the work it amplifies it offering a steadier sustainable fat loss curve without jittery crashes

On April 30, 2026, the FDA proposed formally excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulks List - which would eliminate the remaining legal pathway for 503B outsourcing facilities to compound these medications in bulk

This rotation schedule applies to compounded semaglutide and other GLP-1 medications, since the delivery device changes, but the rotation logic does not